CA2427576C - Benzodiazepine derivatives as gaba a receptor modulators - Google Patents

Benzodiazepine derivatives as gaba a receptor modulators Download PDF

Info

Publication number
CA2427576C
CA2427576C CA002427576A CA2427576A CA2427576C CA 2427576 C CA2427576 C CA 2427576C CA 002427576 A CA002427576 A CA 002427576A CA 2427576 A CA2427576 A CA 2427576A CA 2427576 C CA2427576 C CA 2427576C
Authority
CA
Canada
Prior art keywords
benzodiazepine
triazolo
imidazo
carboxylate
oxadiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002427576A
Other languages
English (en)
French (fr)
Other versions
CA2427576A1 (en
Inventor
Raffaello Masciadri
Andrew William Thomas
Juergen Wichmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA2427576A1 publication Critical patent/CA2427576A1/en
Application granted granted Critical
Publication of CA2427576C publication Critical patent/CA2427576C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002427576A 2000-11-16 2001-11-08 Benzodiazepine derivatives as gaba a receptor modulators Expired - Fee Related CA2427576C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16
EP00124332.8 2000-11-16
PCT/EP2001/012887 WO2002040487A2 (en) 2000-11-16 2001-11-08 Benzodiazepine derivatives as gaba a receptor modulators

Publications (2)

Publication Number Publication Date
CA2427576A1 CA2427576A1 (en) 2002-05-23
CA2427576C true CA2427576C (en) 2007-11-06

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002427576A Expired - Fee Related CA2427576C (en) 2000-11-16 2001-11-08 Benzodiazepine derivatives as gaba a receptor modulators

Country Status (40)

Country Link
US (1) US6743789B2 (cg-RX-API-DMAC7.html)
EP (1) EP1337535B1 (cg-RX-API-DMAC7.html)
JP (1) JP4088151B2 (cg-RX-API-DMAC7.html)
KR (1) KR100504300B1 (cg-RX-API-DMAC7.html)
CN (1) CN1191255C (cg-RX-API-DMAC7.html)
AR (1) AR031345A1 (cg-RX-API-DMAC7.html)
AT (1) ATE268776T1 (cg-RX-API-DMAC7.html)
AU (2) AU2002217007B2 (cg-RX-API-DMAC7.html)
BG (1) BG107817A (cg-RX-API-DMAC7.html)
BR (1) BR0115393A (cg-RX-API-DMAC7.html)
CA (1) CA2427576C (cg-RX-API-DMAC7.html)
CZ (1) CZ295256B6 (cg-RX-API-DMAC7.html)
DE (1) DE60103776T2 (cg-RX-API-DMAC7.html)
DK (1) DK1337535T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP034607A (cg-RX-API-DMAC7.html)
ES (1) ES2220831T3 (cg-RX-API-DMAC7.html)
GC (1) GC0000375A (cg-RX-API-DMAC7.html)
GT (1) GT200100230A (cg-RX-API-DMAC7.html)
HR (1) HRP20030360A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0303281A3 (cg-RX-API-DMAC7.html)
IL (1) IL155813A0 (cg-RX-API-DMAC7.html)
JO (1) JO2359B1 (cg-RX-API-DMAC7.html)
MA (1) MA26962A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA03004251A (cg-RX-API-DMAC7.html)
MY (1) MY141675A (cg-RX-API-DMAC7.html)
NO (1) NO324706B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ525413A (cg-RX-API-DMAC7.html)
PA (1) PA8532401A1 (cg-RX-API-DMAC7.html)
PE (1) PE20020583A1 (cg-RX-API-DMAC7.html)
PL (1) PL362925A1 (cg-RX-API-DMAC7.html)
PT (1) PT1337535E (cg-RX-API-DMAC7.html)
RU (1) RU2278865C2 (cg-RX-API-DMAC7.html)
SI (1) SI1337535T1 (cg-RX-API-DMAC7.html)
SK (1) SK7232003A3 (cg-RX-API-DMAC7.html)
TR (1) TR200402073T4 (cg-RX-API-DMAC7.html)
TW (1) TWI239333B (cg-RX-API-DMAC7.html)
UY (1) UY27026A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002040487A2 (cg-RX-API-DMAC7.html)
YU (1) YU35603A (cg-RX-API-DMAC7.html)
ZA (1) ZA200303435B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
WO2004113321A1 (ja) * 2003-06-19 2004-12-29 Daiichi Pharmaceutical Co., Ltd. 選択的なアミノ置換基導入法
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
AU2005272627A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
AU2005293820B2 (en) 2004-10-12 2010-11-25 F. Hoffmann-La Roche Ag Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
RU2007114763A (ru) * 2004-10-20 2008-11-27 Ф.Хоффманн-Ля Рош Аг (Ch) Галогенозамещенные производные бензодиазепинов
CA2584259C (en) * 2004-10-20 2013-04-02 F. Hoffmann-La Roche Ag Imidazo-benzodiazepine derivatives
EP1828194B1 (en) 2004-12-14 2008-05-28 F. Hoffmann-Roche AG Tetracyclic imidazo-benzodiazepines as gaba receptors modulators
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
EP1924712B1 (en) * 2005-08-03 2018-10-03 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
BRPI0617204A2 (pt) * 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
WO2009139916A1 (en) * 2008-05-16 2009-11-19 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate hsp90 activity
CA2739900C (en) 2008-11-18 2016-11-08 F. Hoffmann-La Roche Ag Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
SI2370441T1 (sl) * 2008-11-28 2013-12-31 F. Hoffmann-La Roche Ag Arilcikloheksiletri dihidrotetraazabenzoazulenov za uporabo kot antagonisti receptorja vazopresina V1A
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
CA2818025A1 (en) 2010-11-15 2012-05-24 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
EP2897963A4 (en) * 2012-09-21 2016-03-30 Uwm Res Foundation Inc Novel GABAA AGONISTS AND METHOD FOR USE TO COMBAT AIRWAY HYPER REAGIBILITY AND IGNITIONS IN ASTHMA
EP4032889A1 (en) * 2013-12-20 2022-07-27 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CA2990004C (en) 2015-06-19 2024-04-23 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio, Inc. derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
AU2019288382B2 (en) * 2018-06-19 2024-07-25 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
AU2023324882A1 (en) 2022-08-19 2025-03-20 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (cg-RX-API-DMAC7.html) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
WO2002040487A3 (en) 2002-09-26
ES2220831T3 (es) 2004-12-16
ATE268776T1 (de) 2004-06-15
AU2002217007B2 (en) 2006-11-30
IL155813A0 (en) 2003-12-23
KR100504300B1 (ko) 2005-07-28
RU2003116895A (ru) 2005-02-20
ZA200303435B (en) 2004-08-05
GC0000375A (en) 2007-03-31
AU1700702A (en) 2002-05-27
NZ525413A (en) 2005-02-25
TR200402073T4 (tr) 2004-10-21
NO20032208D0 (no) 2003-05-15
MXPA03004251A (es) 2003-09-22
DE60103776T2 (de) 2005-07-14
PA8532401A1 (es) 2002-08-26
BR0115393A (pt) 2004-07-06
PE20020583A1 (es) 2002-07-06
KR20030045192A (ko) 2003-06-09
EP1337535B1 (en) 2004-06-09
CN1474820A (zh) 2004-02-11
DK1337535T3 (da) 2004-10-25
SI1337535T1 (en) 2004-10-31
MY141675A (en) 2010-06-15
BG107817A (bg) 2004-07-30
GT200100230A (es) 2002-07-04
ECSP034607A (es) 2003-06-25
HUP0303281A2 (hu) 2004-01-28
HK1062442A1 (en) 2004-11-05
RU2278865C2 (ru) 2006-06-27
JO2359B1 (en) 2006-12-12
NO20032208L (no) 2003-05-15
PL362925A1 (en) 2004-11-02
YU35603A (sh) 2006-05-25
CZ20031597A3 (cs) 2003-11-12
CA2427576A1 (en) 2002-05-23
PT1337535E (pt) 2004-09-30
CN1191255C (zh) 2005-03-02
DE60103776D1 (de) 2004-07-15
HUP0303281A3 (en) 2005-05-30
AR031345A1 (es) 2003-09-17
NO324706B1 (no) 2007-12-03
MA26962A1 (fr) 2004-12-20
JP4088151B2 (ja) 2008-05-21
CZ295256B6 (cs) 2005-06-15
US20020103371A1 (en) 2002-08-01
SK7232003A3 (en) 2004-03-02
US6743789B2 (en) 2004-06-01
UY27026A1 (es) 2002-06-20
HRP20030360A2 (en) 2005-04-30
TWI239333B (en) 2005-09-11
WO2002040487A2 (en) 2002-05-23
JP2004517070A (ja) 2004-06-10
EP1337535A2 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
CA2427576C (en) Benzodiazepine derivatives as gaba a receptor modulators
AU2002217007A1 (en) Benzodiazepine derivatives as GABA A receptor modulators
JP2690282B2 (ja) イミダゾジアゼピン
AU2002338898B2 (en) Imidazo [1,5-A] pyrimido [5,4-D] benzazepine derivatives as gaba a receptor modulators
JPH0657710B2 (ja) イミダゾジアゼピン誘導体
CA2069382A1 (en) Imidazodiazepine
AU2005299032B2 (en) Imidazo-benzodiazepine derivatives
JPH07116195B2 (ja) ベンゾジアゼピン誘導体、その製法、並びにそれを使用する中枢神経病治療剤
CA2584757C (en) Halogen substituted benzodiazepine derivatives
JPH072727B2 (ja) キナゾリン化合物の製造に有用なオキサジアゾール誘導体
US5100895A (en) Heterocyclic compounds and their preparation and use
SK285913B6 (sk) Deriváty 5-substituovaného-3-oxadiazolyl-1,6-naftyridin-2(1H)-onu
EP0202441A1 (en) Oxadiazolylimidazobenzodiazepines, process for their preparation and pharmaceutical compositions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed